Prednisone

About

Therapy type: Chemotherapy

Therapy strategy: Corticosteroid

Mappings

NCI Thesaurus: Prednisone (coding:ncit:C770)

RxNorm: prednisone (coding:rxcui:8640, coding:omop:1551099)

SNOMED: Prednisone (coding:sctid:116602009, coding:omop:4023242)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations Biomarkers Cancer types Therapies
FDA (1) HC (1) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
FDA (1) HC (1) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
FDA (2) HC (1) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
FDA (2) HC (1) BRCA2 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
FDA (1) HC (1) CD30 + Anaplastic Large Cell Lymphoma Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone
FDA (1) HC (1) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
FDA (1) HC (1) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
FDA (1) HC (1) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
FDA (1) HC (1) BRCA2 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
FDA (1) BCR::ABL1 Acute Lymphoid Leukemia Cytarabine, Dexamethasone, Methotrexate, Ponatinib, Prednisone, Vincristine
FDA (2) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) HC (1) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Burkitt Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Mature B-Cell Neoplasms Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
HC (1) CD30 + Mycosis Fungoides Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone
HC (1) CD30 + Angioimmunoblastic T-Cell Lymphoma Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone
HC (1) CD30 + Peripheral T-Cell lymphoma, NOS Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone